Antihyperalgesic	B:C0243095
effect	I:C0243095
of	O
CB1	O
receptor	I:C0378126
activation	O
involves	O
the	O
modulation	O
of	O
P2X3	O
receptor	I:C0382265
in	O
the	O
primary	O
afferent	O
neuron	O
.	O

Antihyperalgesic	O
effect	I:C0243095
of	O
CB1	B:C0378126
receptor	I:C0378126
activation	O
involves	O
the	O
modulation	O
of	O
P2X3	O
receptor	I:C0382265
in	O
the	O
primary	O
afferent	O
neuron	O
.	O

Antihyperalgesic	O
effect	I:C0243095
of	O
CB1	O
receptor	I:C0378126
activation	B:C1514758
involves	O
the	O
modulation	O
of	O
P2X3	O
receptor	I:C0382265
in	O
the	O
primary	O
afferent	O
neuron	O
.	O

Antihyperalgesic	O
effect	I:C0243095
of	O
CB1	O
receptor	I:C0378126
activation	O
involves	O
the	O
modulation	O
of	O
P2X3	B:C0382265
receptor	I:C0382265
in	O
the	O
primary	O
afferent	O
neuron	O
.	O

Antihyperalgesic	O
effect	I:C0243095
of	O
CB1	O
receptor	I:C0378126
activation	O
involves	O
the	O
modulation	O
of	O
P2X3	O
receptor	I:C0382265
in	O
the	O
primary	O
afferent	O
neuron	B:C0027882
.	O

Cannabinoid	B:C0006864
system	I:C0006864
is	O
a	O
potential	O
target	O
for	O
pain	O
control	I:C1304888
.	O

Cannabinoid	O
system	I:C0006864
is	O
a	O
potential	O
target	O
for	O
pain	B:C1304888
control	I:C1304888
.	O

Cannabinoid	B:C0378126
receptor	I:C0378126
1	I:C0378126
(	O
Cannabinoid	O
receptor	I:C0378126
1	I:C0378126
)	O
activation	O
play	O
a	O
role	O
in	O
the	O
analgesic	O
effect	I:C0948482
of	O
cannabinoids	O
once	O
it	O
is	O
expressed	O
in	O
primary	O
afferent	O
neurons	O
.	O

Cannabinoid	O
receptor	I:C0378126
1	I:C0378126
(	O
Cannabinoid	B:C0378126
receptor	I:C0378126
1	I:C0378126
)	O
activation	O
play	O
a	O
role	O
in	O
the	O
analgesic	O
effect	I:C0948482
of	O
cannabinoids	O
once	O
it	O
is	O
expressed	O
in	O
primary	O
afferent	O
neurons	O
.	O

Cannabinoid	O
receptor	I:C0378126
1	I:C0378126
(	O
Cannabinoid	O
receptor	I:C0378126
1	I:C0378126
)	O
activation	O
play	O
a	O
role	O
in	O
the	O
analgesic	B:C0948482
effect	I:C0948482
of	O
cannabinoids	O
once	O
it	O
is	O
expressed	O
in	O
primary	O
afferent	O
neurons	O
.	O

Cannabinoid	O
receptor	I:C0378126
1	I:C0378126
(	O
Cannabinoid	O
receptor	I:C0378126
1	I:C0378126
)	O
activation	O
play	O
a	O
role	O
in	O
the	O
analgesic	O
effect	I:C0948482
of	O
cannabinoids	B:C0006864
once	O
it	O
is	O
expressed	O
in	O
primary	O
afferent	O
neurons	O
.	O

Cannabinoid	O
receptor	I:C0378126
1	I:C0378126
(	O
Cannabinoid	O
receptor	I:C0378126
1	I:C0378126
)	O
activation	O
play	O
a	O
role	O
in	O
the	O
analgesic	O
effect	I:C0948482
of	O
cannabinoids	O
once	O
it	O
is	O
expressed	O
in	O
primary	O
afferent	O
neurons	B:C0027882
.	O

This	O
study	O
investigates	O
whether	O
the	O
anti-hyperalgesic	O
effect	O
of	O
CB1	B:C0378126
receptor	I:C0378126
activation	O
involves	O
P2X3	O
receptor	O
in	O
primary	O
afferent	O
neurons	O
.	O

This	O
study	O
investigates	O
whether	O
the	O
anti-hyperalgesic	O
effect	O
of	O
CB1	O
receptor	I:C0378126
activation	O
involves	O
P2X3	O
receptor	O
in	O
primary	O
afferent	O
neurons	B:C0027882
.	O

Mechanical	B:C2936719
hyperalgesia	I:C2936719
was	O
evaluated	O
by	O
electronic	O
von	I:C0430022
Frey	I:C0430022
test	I:C0430022
.	O

Mechanical	O
hyperalgesia	I:C2936719
was	O
evaluated	O
by	O
electronic	B:C0430022
von	I:C0430022
Frey	I:C0430022
test	I:C0430022
.	O

Cannabinoid	B:C0006864
effect	O
was	O
evaluated	O
using	O
anandamide	O
or	O
ACEA	O
,	O
a	O
non-selective	O
or	O
a	O
selective	O
CB1	O
receptor	I:C1720260
agonists	I:C1720260
,	O
respectively	O
;	O
AM251	O
,	O
a	O
CB1	O
receptor	I:C2927149
antagonist	I:C2927149
,	O
and	O
antisense	O
ODN	I:C0079925
for	O
CB1	O
receptor	I:C0378126
.	O

Cannabinoid	O
effect	O
was	O
evaluated	O
using	O
anandamide	B:C0211726
or	O
ACEA	O
,	O
a	O
non-selective	O
or	O
a	O
selective	O
CB1	O
receptor	I:C1720260
agonists	I:C1720260
,	O
respectively	O
;	O
AM251	O
,	O
a	O
CB1	O
receptor	I:C2927149
antagonist	I:C2927149
,	O
and	O
antisense	O
ODN	I:C0079925
for	O
CB1	O
receptor	I:C0378126
.	O

Cannabinoid	O
effect	O
was	O
evaluated	O
using	O
anandamide	O
or	O
ACEA	B:C0767833
,	O
a	O
non-selective	O
or	O
a	O
selective	O
CB1	O
receptor	I:C1720260
agonists	I:C1720260
,	O
respectively	O
;	O
AM251	O
,	O
a	O
CB1	O
receptor	I:C2927149
antagonist	I:C2927149
,	O
and	O
antisense	O
ODN	I:C0079925
for	O
CB1	O
receptor	I:C0378126
.	O

Cannabinoid	O
effect	O
was	O
evaluated	O
using	O
anandamide	O
or	O
ACEA	O
,	O
a	O
non-selective	O
or	O
a	O
selective	O
CB1	B:C1720260
receptor	I:C1720260
agonists	I:C1720260
,	O
respectively	O
;	O
AM251	O
,	O
a	O
CB1	O
receptor	I:C2927149
antagonist	I:C2927149
,	O
and	O
antisense	O
ODN	I:C0079925
for	O
CB1	O
receptor	I:C0378126
.	O

Cannabinoid	O
effect	O
was	O
evaluated	O
using	O
anandamide	O
or	O
ACEA	O
,	O
a	O
non-selective	O
or	O
a	O
selective	O
CB1	O
receptor	I:C1720260
agonists	I:C1720260
,	O
respectively	O
;	O
AM251	B:C0534009
,	O
a	O
CB1	O
receptor	I:C2927149
antagonist	I:C2927149
,	O
and	O
antisense	O
ODN	I:C0079925
for	O
CB1	O
receptor	I:C0378126
.	O

Cannabinoid	O
effect	O
was	O
evaluated	O
using	O
anandamide	O
or	O
ACEA	O
,	O
a	O
non-selective	O
or	O
a	O
selective	O
CB1	O
receptor	I:C1720260
agonists	I:C1720260
,	O
respectively	O
;	O
AM251	O
,	O
a	O
CB1	B:C2927149
receptor	I:C2927149
antagonist	I:C2927149
,	O
and	O
antisense	O
ODN	I:C0079925
for	O
CB1	O
receptor	I:C0378126
.	O

Cannabinoid	O
effect	O
was	O
evaluated	O
using	O
anandamide	O
or	O
ACEA	O
,	O
a	O
non-selective	O
or	O
a	O
selective	O
CB1	O
receptor	I:C1720260
agonists	I:C1720260
,	O
respectively	O
;	O
AM251	O
,	O
a	O
CB1	O
receptor	I:C2927149
antagonist	I:C2927149
,	O
and	O
antisense	B:C0079925
ODN	I:C0079925
for	O
CB1	O
receptor	I:C0378126
.	O

Cannabinoid	O
effect	O
was	O
evaluated	O
using	O
anandamide	O
or	O
ACEA	O
,	O
a	O
non-selective	O
or	O
a	O
selective	O
CB1	O
receptor	I:C1720260
agonists	I:C1720260
,	O
respectively	O
;	O
AM251	O
,	O
a	O
CB1	O
receptor	I:C2927149
antagonist	I:C2927149
,	O
and	O
antisense	O
ODN	I:C0079925
for	O
CB1	B:C0378126
receptor	I:C0378126
.	O

Calcium	B:C0006675
imaging	O
assay	I:C0079595
was	O
performed	O
to	O
evaluated	O
α,	O
β-	I:C0051285
meATP	I:C0051285
-	O
responsive	O
cultured	O
DRG	O
neurons	O
pretreated	O
with	O
ACEA	O
.	O

Calcium	O
imaging	B:C0079595
assay	I:C0079595
was	O
performed	O
to	O
evaluated	O
α,	O
β-	I:C0051285
meATP	I:C0051285
-	O
responsive	O
cultured	O
DRG	O
neurons	O
pretreated	O
with	O
ACEA	O
.	O

Calcium	O
imaging	O
assay	I:C0079595
was	O
performed	O
to	O
evaluated	O
α,	B:C0051285
β-	I:C0051285
meATP	I:C0051285
-	O
responsive	O
cultured	O
DRG	O
neurons	O
pretreated	O
with	O
ACEA	O
.	O

Calcium	O
imaging	O
assay	I:C0079595
was	O
performed	O
to	O
evaluated	O
α,	O
β-	I:C0051285
meATP	I:C0051285
-	O
responsive	O
cultured	O
DRG	B:C0017070
neurons	O
pretreated	O
with	O
ACEA	O
.	O

Calcium	O
imaging	O
assay	I:C0079595
was	O
performed	O
to	O
evaluated	O
α,	O
β-	I:C0051285
meATP	I:C0051285
-	O
responsive	O
cultured	O
DRG	O
neurons	B:C0027882
pretreated	O
with	O
ACEA	O
.	O

Calcium	O
imaging	O
assay	I:C0079595
was	O
performed	O
to	O
evaluated	O
α,	O
β-	I:C0051285
meATP	I:C0051285
-	O
responsive	O
cultured	O
DRG	O
neurons	O
pretreated	O
with	O
ACEA	B:C0767833
.	O

Anandamide	B:C0211726
or	O
ACEA	O
administered	O
in	O
peripheral	O
tissue	O
reduced	O
the	O
carrageenan	O
-	O
induced	O
mechanical	O
hyperalgesia	I:C2936719
.	O

Anandamide	O
or	O
ACEA	B:C0767833
administered	O
in	O
peripheral	O
tissue	O
reduced	O
the	O
carrageenan	O
-	O
induced	O
mechanical	O
hyperalgesia	I:C2936719
.	O

Anandamide	O
or	O
ACEA	O
administered	O
in	O
peripheral	O
tissue	O
reduced	O
the	O
carrageenan	B:C0007289
-	O
induced	O
mechanical	O
hyperalgesia	I:C2936719
.	O

Anandamide	O
or	O
ACEA	O
administered	O
in	O
peripheral	O
tissue	O
reduced	O
the	O
carrageenan	O
-	O
induced	O
mechanical	B:C2936719
hyperalgesia	I:C2936719
.	O

The	O
reduction	O
in	O
the	O
carrageenan	B:C0007289
-	O
induced	O
hyperalgesia	O
induced	O
by	O
ACEA	O
was	O
completely	O
reversed	O
by	O
administration	O
of	O
AM251	O
as	O
well	O
as	O
by	O
the	O
intrathecal	O
treatment	O
with	O
antisense	O
ODN	I:C0079925
for	O
CB1	O
receptor	I:C0378126
.	O

The	O
reduction	O
in	O
the	O
carrageenan	O
-	O
induced	O
hyperalgesia	B:C2936719
induced	O
by	O
ACEA	O
was	O
completely	O
reversed	O
by	O
administration	O
of	O
AM251	O
as	O
well	O
as	O
by	O
the	O
intrathecal	O
treatment	O
with	O
antisense	O
ODN	I:C0079925
for	O
CB1	O
receptor	I:C0378126
.	O

The	O
reduction	O
in	O
the	O
carrageenan	O
-	O
induced	O
hyperalgesia	O
induced	O
by	O
ACEA	B:C0767833
was	O
completely	O
reversed	O
by	O
administration	O
of	O
AM251	O
as	O
well	O
as	O
by	O
the	O
intrathecal	O
treatment	O
with	O
antisense	O
ODN	I:C0079925
for	O
CB1	O
receptor	I:C0378126
.	O

The	O
reduction	O
in	O
the	O
carrageenan	O
-	O
induced	O
hyperalgesia	O
induced	O
by	O
ACEA	O
was	O
completely	O
reversed	O
by	O
administration	O
of	O
AM251	B:C0534009
as	O
well	O
as	O
by	O
the	O
intrathecal	O
treatment	O
with	O
antisense	O
ODN	I:C0079925
for	O
CB1	O
receptor	I:C0378126
.	O

The	O
reduction	O
in	O
the	O
carrageenan	O
-	O
induced	O
hyperalgesia	O
induced	O
by	O
ACEA	O
was	O
completely	O
reversed	O
by	O
administration	O
of	O
AM251	O
as	O
well	O
as	O
by	O
the	O
intrathecal	O
treatment	O
with	O
antisense	B:C0079925
ODN	I:C0079925
for	O
CB1	O
receptor	I:C0378126
.	O

The	O
reduction	O
in	O
the	O
carrageenan	O
-	O
induced	O
hyperalgesia	O
induced	O
by	O
ACEA	O
was	O
completely	O
reversed	O
by	O
administration	O
of	O
AM251	O
as	O
well	O
as	O
by	O
the	O
intrathecal	O
treatment	O
with	O
antisense	O
ODN	I:C0079925
for	O
CB1	B:C0378126
receptor	I:C0378126
.	O

Also	O
,	O
ACEA	B:C0767833
reduced	O
the	O
mechanical	O
hyperalgesia	I:C2936719
induced	O
by	O
bradykinin	O
and	O
by	O
α	O
,	I:C0051285
β-	I:C0051285
meATP	I:C0051285
,	O
a	O
P2X3	O
receptor	I:C0382265
non-selective	O
agonist	O
,	O
but	O
not	O
by	O
tumor	O
necrosis	I:C1456820
factor	I:C1456820
alpha	I:C1456820
(	O
tumor	O
necrosis	I:C1456820
factor	I:C1456820
alpha	I:C1456820
)	O
,	O
interleukin	O
-	I:C0021753
1	I:C0021753
beta	I:C0021753
(	O
interleukin	O
-	I:C0021753
1	I:C0021753
beta	I:C0021753
)	O
and	O
chemokine	O
-	O
induced	O
chemoattractant	O
-	I:C0033684
1	I:C0033684
(	O
chemokine	O
-	I:C0033684
induced	I:C0033684
chemoattractant	I:C0033684
-	I:C0033684
1	I:C0033684
)	O
.	O

Also	O
,	O
ACEA	O
reduced	O
the	O
mechanical	B:C2936719
hyperalgesia	I:C2936719
induced	O
by	O
bradykinin	O
and	O
by	O
α	O
,	I:C0051285
β-	I:C0051285
meATP	I:C0051285
,	O
a	O
P2X3	O
receptor	I:C0382265
non-selective	O
agonist	O
,	O
but	O
not	O
by	O
tumor	O
necrosis	I:C1456820
factor	I:C1456820
alpha	I:C1456820
(	O
tumor	O
necrosis	I:C1456820
factor	I:C1456820
alpha	I:C1456820
)	O
,	O
interleukin	O
-	I:C0021753
1	I:C0021753
beta	I:C0021753
(	O
interleukin	O
-	I:C0021753
1	I:C0021753
beta	I:C0021753
)	O
and	O
chemokine	O
-	O
induced	O
chemoattractant	O
-	I:C0033684
1	I:C0033684
(	O
chemokine	O
-	I:C0033684
induced	I:C0033684
chemoattractant	I:C0033684
-	I:C0033684
1	I:C0033684
)	O
.	O

Also	O
,	O
ACEA	O
reduced	O
the	O
mechanical	O
hyperalgesia	I:C2936719
induced	O
by	O
bradykinin	O
and	O
by	O
α	B:C0051285
,	I:C0051285
β-	I:C0051285
meATP	I:C0051285
,	O
a	O
P2X3	O
receptor	I:C0382265
non-selective	O
agonist	O
,	O
but	O
not	O
by	O
tumor	O
necrosis	I:C1456820
factor	I:C1456820
alpha	I:C1456820
(	O
tumor	O
necrosis	I:C1456820
factor	I:C1456820
alpha	I:C1456820
)	O
,	O
interleukin	O
-	I:C0021753
1	I:C0021753
beta	I:C0021753
(	O
interleukin	O
-	I:C0021753
1	I:C0021753
beta	I:C0021753
)	O
and	O
chemokine	O
-	O
induced	O
chemoattractant	O
-	I:C0033684
1	I:C0033684
(	O
chemokine	O
-	I:C0033684
induced	I:C0033684
chemoattractant	I:C0033684
-	I:C0033684
1	I:C0033684
)	O
.	O

Also	O
,	O
ACEA	O
reduced	O
the	O
mechanical	O
hyperalgesia	I:C2936719
induced	O
by	O
bradykinin	O
and	O
by	O
α	O
,	I:C0051285
β-	I:C0051285
meATP	I:C0051285
,	O
a	O
P2X3	B:C0382265
receptor	I:C0382265
non-selective	O
agonist	O
,	O
but	O
not	O
by	O
tumor	O
necrosis	I:C1456820
factor	I:C1456820
alpha	I:C1456820
(	O
tumor	O
necrosis	I:C1456820
factor	I:C1456820
alpha	I:C1456820
)	O
,	O
interleukin	O
-	I:C0021753
1	I:C0021753
beta	I:C0021753
(	O
interleukin	O
-	I:C0021753
1	I:C0021753
beta	I:C0021753
)	O
and	O
chemokine	O
-	O
induced	O
chemoattractant	O
-	I:C0033684
1	I:C0033684
(	O
chemokine	O
-	I:C0033684
induced	I:C0033684
chemoattractant	I:C0033684
-	I:C0033684
1	I:C0033684
)	O
.	O

Also	O
,	O
ACEA	O
reduced	O
the	O
mechanical	O
hyperalgesia	I:C2936719
induced	O
by	O
bradykinin	O
and	O
by	O
α	O
,	I:C0051285
β-	I:C0051285
meATP	I:C0051285
,	O
a	O
P2X3	O
receptor	I:C0382265
non-selective	O
agonist	B:C1720260
,	O
but	O
not	O
by	O
tumor	O
necrosis	I:C1456820
factor	I:C1456820
alpha	I:C1456820
(	O
tumor	O
necrosis	I:C1456820
factor	I:C1456820
alpha	I:C1456820
)	O
,	O
interleukin	O
-	I:C0021753
1	I:C0021753
beta	I:C0021753
(	O
interleukin	O
-	I:C0021753
1	I:C0021753
beta	I:C0021753
)	O
and	O
chemokine	O
-	O
induced	O
chemoattractant	O
-	I:C0033684
1	I:C0033684
(	O
chemokine	O
-	I:C0033684
induced	I:C0033684
chemoattractant	I:C0033684
-	I:C0033684
1	I:C0033684
)	O
.	O

Also	O
,	O
ACEA	O
reduced	O
the	O
mechanical	O
hyperalgesia	I:C2936719
induced	O
by	O
bradykinin	O
and	O
by	O
α	O
,	I:C0051285
β-	I:C0051285
meATP	I:C0051285
,	O
a	O
P2X3	O
receptor	I:C0382265
non-selective	O
agonist	O
,	O
but	O
not	O
by	O
tumor	B:C1456820
necrosis	I:C1456820
factor	I:C1456820
alpha	I:C1456820
(	O
tumor	O
necrosis	I:C1456820
factor	I:C1456820
alpha	I:C1456820
)	O
,	O
interleukin	O
-	I:C0021753
1	I:C0021753
beta	I:C0021753
(	O
interleukin	O
-	I:C0021753
1	I:C0021753
beta	I:C0021753
)	O
and	O
chemokine	O
-	O
induced	O
chemoattractant	O
-	I:C0033684
1	I:C0033684
(	O
chemokine	O
-	I:C0033684
induced	I:C0033684
chemoattractant	I:C0033684
-	I:C0033684
1	I:C0033684
)	O
.	O

Also	O
,	O
ACEA	O
reduced	O
the	O
mechanical	O
hyperalgesia	I:C2936719
induced	O
by	O
bradykinin	O
and	O
by	O
α	O
,	I:C0051285
β-	I:C0051285
meATP	I:C0051285
,	O
a	O
P2X3	O
receptor	I:C0382265
non-selective	O
agonist	O
,	O
but	O
not	O
by	O
tumor	O
necrosis	I:C1456820
factor	I:C1456820
alpha	I:C1456820
(	O
tumor	B:C1456820
necrosis	I:C1456820
factor	I:C1456820
alpha	I:C1456820
)	O
,	O
interleukin	O
-	I:C0021753
1	I:C0021753
beta	I:C0021753
(	O
interleukin	O
-	I:C0021753
1	I:C0021753
beta	I:C0021753
)	O
and	O
chemokine	O
-	O
induced	O
chemoattractant	O
-	I:C0033684
1	I:C0033684
(	O
chemokine	O
-	I:C0033684
induced	I:C0033684
chemoattractant	I:C0033684
-	I:C0033684
1	I:C0033684
)	O
.	O

Also	O
,	O
ACEA	O
reduced	O
the	O
mechanical	O
hyperalgesia	I:C2936719
induced	O
by	O
bradykinin	O
and	O
by	O
α	O
,	I:C0051285
β-	I:C0051285
meATP	I:C0051285
,	O
a	O
P2X3	O
receptor	I:C0382265
non-selective	O
agonist	O
,	O
but	O
not	O
by	O
tumor	O
necrosis	I:C1456820
factor	I:C1456820
alpha	I:C1456820
(	O
tumor	O
necrosis	I:C1456820
factor	I:C1456820
alpha	I:C1456820
)	O
,	O
interleukin	B:C0021753
-	I:C0021753
1	I:C0021753
beta	I:C0021753
(	O
interleukin	O
-	I:C0021753
1	I:C0021753
beta	I:C0021753
)	O
and	O
chemokine	O
-	O
induced	O
chemoattractant	O
-	I:C0033684
1	I:C0033684
(	O
chemokine	O
-	I:C0033684
induced	I:C0033684
chemoattractant	I:C0033684
-	I:C0033684
1	I:C0033684
)	O
.	O

Also	O
,	O
ACEA	O
reduced	O
the	O
mechanical	O
hyperalgesia	I:C2936719
induced	O
by	O
bradykinin	O
and	O
by	O
α	O
,	I:C0051285
β-	I:C0051285
meATP	I:C0051285
,	O
a	O
P2X3	O
receptor	I:C0382265
non-selective	O
agonist	O
,	O
but	O
not	O
by	O
tumor	O
necrosis	I:C1456820
factor	I:C1456820
alpha	I:C1456820
(	O
tumor	O
necrosis	I:C1456820
factor	I:C1456820
alpha	I:C1456820
)	O
,	O
interleukin	O
-	I:C0021753
1	I:C0021753
beta	I:C0021753
(	O
interleukin	B:C0021753
-	I:C0021753
1	I:C0021753
beta	I:C0021753
)	O
and	O
chemokine	O
-	O
induced	O
chemoattractant	O
-	I:C0033684
1	I:C0033684
(	O
chemokine	O
-	I:C0033684
induced	I:C0033684
chemoattractant	I:C0033684
-	I:C0033684
1	I:C0033684
)	O
.	O

Also	O
,	O
ACEA	O
reduced	O
the	O
mechanical	O
hyperalgesia	I:C2936719
induced	O
by	O
bradykinin	O
and	O
by	O
α	O
,	I:C0051285
β-	I:C0051285
meATP	I:C0051285
,	O
a	O
P2X3	O
receptor	I:C0382265
non-selective	O
agonist	O
,	O
but	O
not	O
by	O
tumor	O
necrosis	I:C1456820
factor	I:C1456820
alpha	I:C1456820
(	O
tumor	O
necrosis	I:C1456820
factor	I:C1456820
alpha	I:C1456820
)	O
,	O
interleukin	O
-	I:C0021753
1	I:C0021753
beta	I:C0021753
(	O
interleukin	O
-	I:C0021753
1	I:C0021753
beta	I:C0021753
)	O
and	O
chemokine	B:C0282554
-	O
induced	O
chemoattractant	O
-	I:C0033684
1	I:C0033684
(	O
chemokine	O
-	I:C0033684
induced	I:C0033684
chemoattractant	I:C0033684
-	I:C0033684
1	I:C0033684
)	O
.	O

Also	O
,	O
ACEA	O
reduced	O
the	O
mechanical	O
hyperalgesia	I:C2936719
induced	O
by	O
bradykinin	O
and	O
by	O
α	O
,	I:C0051285
β-	I:C0051285
meATP	I:C0051285
,	O
a	O
P2X3	O
receptor	I:C0382265
non-selective	O
agonist	O
,	O
but	O
not	O
by	O
tumor	O
necrosis	I:C1456820
factor	I:C1456820
alpha	I:C1456820
(	O
tumor	O
necrosis	I:C1456820
factor	I:C1456820
alpha	I:C1456820
)	O
,	O
interleukin	O
-	I:C0021753
1	I:C0021753
beta	I:C0021753
(	O
interleukin	O
-	I:C0021753
1	I:C0021753
beta	I:C0021753
)	O
and	O
chemokine	O
-	O
induced	O
chemoattractant	B:C0033684
-	I:C0033684
1	I:C0033684
(	O
chemokine	O
-	I:C0033684
induced	I:C0033684
chemoattractant	I:C0033684
-	I:C0033684
1	I:C0033684
)	O
.	O

Also	O
,	O
ACEA	O
reduced	O
the	O
mechanical	O
hyperalgesia	I:C2936719
induced	O
by	O
bradykinin	O
and	O
by	O
α	O
,	I:C0051285
β-	I:C0051285
meATP	I:C0051285
,	O
a	O
P2X3	O
receptor	I:C0382265
non-selective	O
agonist	O
,	O
but	O
not	O
by	O
tumor	O
necrosis	I:C1456820
factor	I:C1456820
alpha	I:C1456820
(	O
tumor	O
necrosis	I:C1456820
factor	I:C1456820
alpha	I:C1456820
)	O
,	O
interleukin	O
-	I:C0021753
1	I:C0021753
beta	I:C0021753
(	O
interleukin	O
-	I:C0021753
1	I:C0021753
beta	I:C0021753
)	O
and	O
chemokine	O
-	O
induced	O
chemoattractant	O
-	I:C0033684
1	I:C0033684
(	O
chemokine	B:C0033684
-	I:C0033684
induced	I:C0033684
chemoattractant	I:C0033684
-	I:C0033684
1	I:C0033684
)	O
.	O

Finally	O
,	O
CB1	B:C0378126
receptor	I:C0378126
s	O
are	O
co-localized	O
with	O
P2X3	O
receptors	I:C0382265
in	O
DRG	O
small	O
-	O
diameter	O
neurons	O
and	O
the	O
treatment	O
with	O
ACEA	O
reduced	O
the	O
number	O
of	O
α	O
,	I:C0051285
β-	I:C0051285
meATP	I:C0051285
-	O
responsive	O
cultured	O
DRG	O
neurons	O
.	O

Finally	O
,	O
CB1	O
receptor	I:C0378126
s	O
are	O
co-localized	O
with	O
P2X3	B:C0382265
receptors	I:C0382265
in	O
DRG	O
small	O
-	O
diameter	O
neurons	O
and	O
the	O
treatment	O
with	O
ACEA	O
reduced	O
the	O
number	O
of	O
α	O
,	I:C0051285
β-	I:C0051285
meATP	I:C0051285
-	O
responsive	O
cultured	O
DRG	O
neurons	O
.	O

Finally	O
,	O
CB1	O
receptor	I:C0378126
s	O
are	O
co-localized	O
with	O
P2X3	O
receptors	I:C0382265
in	O
DRG	B:C0017070
small	O
-	O
diameter	O
neurons	O
and	O
the	O
treatment	O
with	O
ACEA	O
reduced	O
the	O
number	O
of	O
α	O
,	I:C0051285
β-	I:C0051285
meATP	I:C0051285
-	O
responsive	O
cultured	O
DRG	O
neurons	O
.	O

Finally	O
,	O
CB1	O
receptor	I:C0378126
s	O
are	O
co-localized	O
with	O
P2X3	O
receptors	I:C0382265
in	O
DRG	O
small	O
-	O
diameter	O
neurons	B:C0027882
and	O
the	O
treatment	O
with	O
ACEA	O
reduced	O
the	O
number	O
of	O
α	O
,	I:C0051285
β-	I:C0051285
meATP	I:C0051285
-	O
responsive	O
cultured	O
DRG	O
neurons	O
.	O

Finally	O
,	O
CB1	O
receptor	I:C0378126
s	O
are	O
co-localized	O
with	O
P2X3	O
receptors	I:C0382265
in	O
DRG	O
small	O
-	O
diameter	O
neurons	O
and	O
the	O
treatment	O
with	O
ACEA	B:C0767833
reduced	O
the	O
number	O
of	O
α	O
,	I:C0051285
β-	I:C0051285
meATP	I:C0051285
-	O
responsive	O
cultured	O
DRG	O
neurons	O
.	O

Finally	O
,	O
CB1	O
receptor	I:C0378126
s	O
are	O
co-localized	O
with	O
P2X3	O
receptors	I:C0382265
in	O
DRG	O
small	O
-	O
diameter	O
neurons	O
and	O
the	O
treatment	O
with	O
ACEA	O
reduced	O
the	O
number	O
of	O
α	B:C0051285
,	I:C0051285
β-	I:C0051285
meATP	I:C0051285
-	O
responsive	O
cultured	O
DRG	O
neurons	O
.	O

Finally	O
,	O
CB1	O
receptor	I:C0378126
s	O
are	O
co-localized	O
with	O
P2X3	O
receptors	I:C0382265
in	O
DRG	O
small	O
-	O
diameter	O
neurons	O
and	O
the	O
treatment	O
with	O
ACEA	O
reduced	O
the	O
number	O
of	O
α	O
,	I:C0051285
β-	I:C0051285
meATP	I:C0051285
-	O
responsive	O
cultured	O
DRG	B:C0017070
neurons	O
.	O

Finally	O
,	O
CB1	O
receptor	I:C0378126
s	O
are	O
co-localized	O
with	O
P2X3	O
receptors	I:C0382265
in	O
DRG	O
small	O
-	O
diameter	O
neurons	O
and	O
the	O
treatment	O
with	O
ACEA	O
reduced	O
the	O
number	O
of	O
α	O
,	I:C0051285
β-	I:C0051285
meATP	I:C0051285
-	O
responsive	O
cultured	O
DRG	O
neurons	B:C0027882
.	O

Our	O
data	O
suggest	O
that	O
the	O
analgesic	B:C0948482
effect	I:C0948482
of	O
CB1	O
receptor	I:C0378126
activation	O
is	O
mediated	O
by	O
a	O
negative	O
modulation	O
of	O
the	O
P2X3	O
receptor	I:C0382265
in	O
the	O
primary	O
afferent	O
neurons	O
.	O

Our	O
data	O
suggest	O
that	O
the	O
analgesic	O
effect	I:C0948482
of	O
CB1	B:C0378126
receptor	I:C0378126
activation	O
is	O
mediated	O
by	O
a	O
negative	O
modulation	O
of	O
the	O
P2X3	O
receptor	I:C0382265
in	O
the	O
primary	O
afferent	O
neurons	O
.	O

Our	O
data	O
suggest	O
that	O
the	O
analgesic	O
effect	I:C0948482
of	O
CB1	O
receptor	I:C0378126
activation	B:C1514758
is	O
mediated	O
by	O
a	O
negative	O
modulation	O
of	O
the	O
P2X3	O
receptor	I:C0382265
in	O
the	O
primary	O
afferent	O
neurons	O
.	O

Our	O
data	O
suggest	O
that	O
the	O
analgesic	O
effect	I:C0948482
of	O
CB1	O
receptor	I:C0378126
activation	O
is	O
mediated	O
by	O
a	O
negative	O
modulation	O
of	O
the	O
P2X3	B:C0382265
receptor	I:C0382265
in	O
the	O
primary	O
afferent	O
neurons	O
.	O

Our	O
data	O
suggest	O
that	O
the	O
analgesic	O
effect	I:C0948482
of	O
CB1	O
receptor	I:C0378126
activation	O
is	O
mediated	O
by	O
a	O
negative	O
modulation	O
of	O
the	O
P2X3	O
receptor	I:C0382265
in	O
the	O
primary	O
afferent	O
neurons	B:C0027882
.	O

